Author Login IJIRT Partner Network (IPN) Login

IN-VITRO GENOTOXIC EVALUATION OF THE SULFASLAZINE IMPURITY - (2-HYDROXY-5-[N-(4-{[4 -PYRIDIN- 2 -YLSULFAMOYL) PHENYL] SULFAMOYL}PHENYL)DIAZEN-1-YL]) BENZOIC ACID BY CHO CHROMOSOMAL ABERRATION TEST

  • Unique Paper ID: 157542
  • Volume: 9
  • Issue: 7
  • PageNo: 449-456
  • Abstract:
  • (2-hydroxy-5-[N-(4-{[4 -pyridin- 2 -ylsulfamoyl) phenyl] sulfamoyl}phenyl)diazen-1-yl]) benzoic acid is identified as impurity in Sulfasalazine drug. This impurity considered as in-house impurity since regulatory agencies not reported completely. It is mandatory to test toxicology effects of this impurity for regulatory compliance. The chromosome aberration test is one of the sensitive methods to identify or evaluate the mutagenicity of environmental mutagens and/or carcinogens using cultured mammalian cells. This study the clastogenic activity was tested by chromosomal aberration test by using CHO cell lines. Several chromosomal abnormalities were tested in this experiment. This experiment result was insignificant pertaining to Chromosomal aberrations. Chromosomes of Cell lines does not show any abnormality in any given concentration of the impurity.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 9
  • Issue: 7
  • PageNo: 449-456

IN-VITRO GENOTOXIC EVALUATION OF THE SULFASLAZINE IMPURITY - (2-HYDROXY-5-[N-(4-{[4 -PYRIDIN- 2 -YLSULFAMOYL) PHENYL] SULFAMOYL}PHENYL)DIAZEN-1-YL]) BENZOIC ACID BY CHO CHROMOSOMAL ABERRATION TEST

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry